Baker McKenzie has added Rod Hunter as a Partner in its North America International Commercial Group in Washington, DC. Mr. Hunter brings more than 30 years of experience in a range of international trade, regulatory and policy matters, with a focus in the pharmaceutical and technology industries.
Most recently, Mr. Hunter served as Senior Vice President for International Affairs at the Pharmaceutical Research and Manufacturers Association (PhRMA) in Washington, DC, where he led the association's international advocacy. Prior to joining PhRMA, Mr. Hunter directed IBM's governmental programs in Europe, representing the company on competition, technology and intellectual property, among other policy and regulatory matters. He also served as Senior Director at the White House’s National Security Council, where he coordinated the administration’s international economic agenda under President George W. Bush.
"Rod is highly regarded among chief executives and government affairs leaders at biopharmaceutical companies, and he has wide-ranging regulatory and policy experience that spans borders," said Miguel Noyola, Chair of the Firm's North America International Commercial Practice. "His diverse background practicing regulatory law in Europe and the United States will benefit clients in businesses in a variety of sectors."
Added Nick Coward, a Partner in Washington, DC, "Rod's impressive background and deep policy expertise will perfectly complement the offerings of our International Commercial Practice, and I look forward to working with him."
Mr. Hunter has published and lectured widely on regulatory and trade challenges for international business. He also serves as both a lecturer on international trade and a member of the Advisory Board at the Batten School of Leadership and Public Policy at the University of Virginia, and he is a senior non-resident fellow of the German Marshall Fund.
"We continue to further enhance our practices throughout North America with the addition of top practitioners," said Rick Hammett, Managing Partner of the Firm's North American region. "Rod is another outstanding addition to our team whose knowledge of international policy and regulatory law in Europe and the US will be highly valuable to our clients."
The Firm's North America International Commercial Practice advises multinational companies on legal issues that impact their global business strategies, operating out of a network that spans 47 countries. Ranked by both Chambers and Legal 500, the practice helps clients overcome the challenges of international trade sanctions and customs laws and successfully compete in the world's developed and emerging markets.
In addition, the Firm continues to add attorneys with expertise in the healthcare industry. For example, FDA regulatory attorneys Neil O'Flaherty and Jur Strobos recently joined in Washington, DC.
Mr. Hunter joining the Firm's International Commercial Practice follows the arrival of international trade and investment advisor James Small and data privacy lawyer Dean Dolan, who both joined the Firm in Toronto. In addition, franchising lawyer Maggie Vaughan and global transactions attorney Sonia Baldia recently joined in Washington, DC. Overall, Baker McKenzie has added more than 40 lateral partners in North America over the last two years, as it continues to strengthen its presence in key markets.
I look forward to bringing my policy experience to Baker McKenzie and working with colleagues across practice groups to further strengthen the services we offer to clients,
said Mr. Hunter.